fulvestrant has been researched along with puerarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, Y; Michihara, S; Moriyama, T; Tanaka, T; Uzawa, Y | 1 |
| Che, T; Cheng, J; Liu, L; Lv, H; Tang, X | 1 |
2 other study(ies) available for fulvestrant and puerarin
| Article | Year |
|---|---|
Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway.
Topics: Acid Phosphatase; Amino Acids; Animals; Breast Neoplasms; Cell Proliferation; Diet; Estradiol; Female; Fulvestrant; Humans; Isoflavones; MCF-7 Cells; Mice; Osteocalcin; Osteoporosis; Ovariectomy; Pueraria; Receptors, Estrogen | 2012 |
Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bone Marrow Cells; Calcium; Cell Differentiation; Cell Proliferation; Core Binding Factor Alpha 1 Subunit; Cyclic GMP; Dose-Response Relationship, Drug; Estradiol; Female; Fulvestrant; Gene Expression Regulation; Humans; Isoflavones; Male; Middle Aged; Nitric Oxide; Nitroarginine; Osteoblasts; Osteocalcin; Primary Cell Culture; Signal Transduction; Sp7 Transcription Factor; Stromal Cells; Transcription Factors | 2015 |